TGFB1 and Myocardial fibrosis: Previous work showed that AST-IV could attenuate myocardial fibrosis by inhibiting TGF-β1 signalling in CVB3-induced cardiomyopathy and exert antiviral effects against CVB3 by up-regulating expression of IFN-γ mRNA 27,28.